Search

Home > New FDA Approvals > 136 - Pembrolizumab + pemetrexed for NSCLC; FDA clearance for the LungVision tool; cemiplimab for advanced cutaneous squamous cell carcinoma
Podcast: New FDA Approvals
Episode:

136 - Pembrolizumab + pemetrexed for NSCLC; FDA clearance for the LungVision tool; cemiplimab for advanced cutaneous squamous cell carcinoma
Category: Science & Medicine
Duration: 00:08:18
Publish Date: 2018-04-30 06:00:00
Description:

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

April 30, 2018 

1:16 FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and Platinum Chemotherapy Based on Results from Phase 3 KEYNOTE-189 Trial as First-Line Treatment of Metastatic Nonsquamous NSCLC http://www.mrknewsroom.com/news-release/oncology/fda-grants-priority-review-mercks-sbla-keytruda-pembrolizumab-combination-peme

3:09 Body Vision Medical Receives FDA Clearance for the LungVision Tool, Part of the LungVision Platform https://www.prnewswire.com/news-releases/body-vision-medical-receives-fda-clearance-for-the-lungvision-tool-part-of-the-lungvision-platform-revolutionizing-the-areas-of-lung-cancer-diagnostics-and-treatment-300638819.html 

4:39 FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma https://www.prnewswire.com/news-releases/fda-to-conduct-priority-review-of-cemiplimab-as-a-potential-treatment-for-advanced-cutaneous-squamous-cell-carcinoma-300638568.html

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0